PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1003
https://www.valueinhealthjournal.com/article/S1098-3015(12)02716-7/fulltext
Title : PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02716-7&doi=10.1016/j.jval.2012.08.1003
First page : A373
Section Title : Cardiovascular Disorders
Open access? : No
Section Order : 512
Categories :
Tags :
Regions :
ViH Article Tags :